Q2 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABCL | New | ABCELLERA BIOLOGICS INC | $24,377,004 | – | 3,773,530 | – | 91.35% | – |
| CMPS | New | COMPASS PATHWAYS PLCsponsored ads | $2,309,126 | – | 278,880 | – | 8.65% | – |
Q4 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CMPS | Exit | COMPASS PATHWAYS PLCsponsored ads | $0 | – | -278,880 | – | -7.42% | – |
| ABCL | Exit | ABCELLERA BIOLOGICS INC | $0 | – | -3,773,530 | – | -92.58% | – |
Q2 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABCL | New | ABCELLERA BIOLOGICS INC | $40,188,000 | – | 3,773,530 | – | 93.02% | – |
| CMPS | New | COMPASS PATHWAYS PLCsponsored ads | $3,017,000 | – | 278,880 | – | 6.98% | – |
Q4 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CMPS | Exit | COMPASS PATHWAYS PLCsponsored ads | $0 | – | -408,410 | – | -13.90% | – |
| ABCL | Exit | ABCELLERA BIOLOGICS INC | $0 | – | -3,773,530 | – | -86.10% | – |
Q3 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CMPS | Sell | COMPASS PATHWAYS PLCsponsored ads | $12,199,000 | -42.7% | 408,410 | -26.8% | 13.90% | -31.9% |
Q2 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABCL | New | ABCELLERA BIOLOGICS INC | $83,018,000 | – | 3,773,530 | – | 79.60% | – |
| CMPS | New | COMPASS PATHWAYS PLCsponsored ads | $21,279,000 | – | 557,760 | – | 20.40% | – |